| BOC Sciences | USA | Inquire | ||
|---|---|---|---|---|
![]() | www.bocsci.com | |||
![]() | +1 (631) 485-4226 | |||
![]() | +1 (631) 614-7828 | |||
![]() | info@bocsci.com | |||
| Chemical manufacturer | ||||
| chemBlink Standard supplier since 2010 | ||||
| Creative Peptides | USA | Inquire | ||
|---|---|---|---|---|
![]() | www.creative-peptides.com | |||
![]() | +1 (631) 624-4882 | |||
![]() | +1 (631) 614-7828 | |||
![]() | info@creative-peptides.com | |||
| Chemical manufacturer | ||||
| chemBlink Standard supplier since 2010 | ||||
| Biosynth AG. | Switzerland | Inquire | ||
|---|---|---|---|---|
![]() | www.biosynth.com | |||
![]() | +41 (71) 858-2020 | |||
![]() | +41 (71) 858-2030 | |||
![]() | welcome@biosynth.ch | |||
| Chemical manufacturer | ||||
| chemBlink Standard supplier since 2014 | ||||
| Hangzhou Leap Chem Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() | www.leapchem.com | |||
![]() | +86 (571) 8771-1850 | |||
![]() | market19@leapchem.com | |||
![]() | QQ Chat | |||
| Chemical manufacturer since 2006 | ||||
| chemBlink Standard supplier since 2015 | ||||
| Peptides International, Inc. | USA | Inquire | ||
|---|---|---|---|---|
![]() | www.pepnet.com | |||
![]() | +1 (502) 266-8787 (800) 777-4779 | |||
![]() | +1 (502) 267-1329 | |||
![]() | peptides@pepnet.com | |||
| Chemical manufacturer since 1983 | ||||
| Watanabe Chemical Ind., Ltd. | Japan | Inquire | ||
|---|---|---|---|---|
![]() | www.watanabechem.co.jp | |||
![]() | +81 (82) 231-0540 | |||
![]() | +81 (82) 231-1451 | |||
![]() | inquiry@watanabechem.co.jp | |||
| Chemical manufacturer | ||||
| Name | L-Penicillamine |
|---|---|
| Synonyms | L-(+)-Penicillamine; 3-Mercapto-L-valine |
| Molecular Structure | ![]() |
| Molecular Formula | C5H11NO2S |
| Molecular Weight | 149.21 |
| CAS Registry Number | 1113-41-3 |
| EC Number | 214-203-9 |
| Melting point | 206 °C (dec.) |
|---|---|
| alpha | 61.9 ° (c=0.5 in 1 M NaOH) |
| Hazard Symbols | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Risk Statements | R36/37/38 Details | ||||||||||||||||||||
| Safety Statements | S26 Details | ||||||||||||||||||||
| Hazard Classification | |||||||||||||||||||||
| |||||||||||||||||||||
| SDS | Available | ||||||||||||||||||||
| Market Analysis Reports |
| List of Reports Available for L-Penicillamine |